ArticleThe New England journal of medicine2015
The proposed rule for U.S. clinical trial registration and results submission.
Article in The New England journal of medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Clinical utility of randomized controlled trials of regional anesthesia for lower-extremity surgery: a systematic review.Regional anesthesia and pain medicine · 2026Pooled it
- Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis.Frontiers in immunology · 2024Pooled it
- Full publication of results initially presented in abstracts.The Cochrane database of systematic reviews · 2018Pooled it
- Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality.PLoS biology · 2018Pooled it
- Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs.Translational psychiatry · 2017Pooled it
- Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.Drugs · 2015Pooled it
- Prospective adverse event risk evaluation in clinical trials.Health care management science · 2022Trial
- A randomized trial to compare procalcitonin and C-reactive protein in assessing severity of sepsis and in guiding antibacterial therapy in Egyptian critically ill patients.Irish journal of medical science · 2021Trial
- PXT3003: Lessons for therapeutic development in Charcot-Marie-Tooth disease type 1A and related neuropathies.iScience · 2026Review
- Stakeholder views about the responsibilities of principal investigators in multicenter randomized controlled trials.Clinical trials (London, England) · 2026Article
- Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023Article
- Article
- Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obesity pillars · 2022Article
- Selective outcome reporting across psychopharmacotherapy randomized controlled trials.International journal of methods in psychiatric research · 2022Article
- Complete ablation of tumors using synchronous chemoradiation with bimetallic theranostic nanoparticles.Bioactive materials · 2022Article
- Article
- Semantic categorization of Chinese eligibility criteria in clinical trials using machine learning methods.BMC medical informatics and decision making · 2021Article
- Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.JAMA network open · 2020Article
- Low dissemination rates, non-transparency of trial premature cessation and late registration in child mental health: observational study of registered interventional trials.European child & adolescent psychiatry · 2020Observational
- Comparisons between protocols and publications of case-control studies: analysis of potential causes of non-reproducibility and recommendations for enhancing the quality of personalization in healthcare.The EPMA journal · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.